logo

Last Update

This profile was last updated on 6/7/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Eric Sievers?

Eric L. Sievers

Chief Medical Officer

Trillium Therapeutics Inc.

HQ Phone:  (416) 595-0627

Direct Phone: (206) ***-****direct phone

Email: e***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Trillium Therapeutics Inc.

96 Skyway Avenue

Toronto, Ontario,M9W 4Y9

Canada

Company Description

Trillium Therapeutics Inc. is a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer. The Company's lead program is a SIRPaFc antibody-like fusion protein that consists of the CD47-binding domain of human SIRPa lin...more

Background Information

Employment History

Executive Medical Director

Cell Therapy News


Senior Vice President - Clinical Development

Seattle Genetics , Inc.


Affiliations

American Association for Cancer Research Inc

Member


American Society of Hematology

Member


American Society of Clinical Oncology

Member


European Hematology Association

Member


Education

B.A.

Biology

Brown University


M.D.

Brown University


Web References(42 Total References)


Trillium Expands Clinical Trial With TTI-621 to Include Combination With PD-1 Blockade - Cantech Letter

www.cantechletter.com [cached]

"Having observed meaningful objective responses among multiple treatment-refractory cancer patients, we are now expanding the trial's scope with additional focused enrollment to extend these preliminary observations and to seek promising new signals of activity - both with TTI-621 monotherapy, with rituximab, and in a novel combination with T-cell checkpoint inhibition," said Trillium's Chief Medical Officer, Dr. Eric Sievers.


www.sec.gov

Eric Sievers
Chief Medical Officer Dr. Sievers is the Chief Medical Officer of Trillium since April 1, 2015. He previously held several senior roles at Seattle Genetics including the Senior Vice President, Clinical Development from October 2013 to March 2015, the Vice President and Interim Chief Medical Officer from 2012 to October 2013, and Vice President, Clinical Affairs from 2011 to 2012, and Executive Medical Director from 2010 to 2011. As Chief Medical Officer, Dr. Sievers is responsible for the design and execution of our clinical and regulatory strategy. Dr. Eric Sievers - Chief Medical Officer Dr. Sievers joined Trillium as Chief Medical Officer on April 1, 2015. Dr. Sievers is responsible for the design and execution of our clinical and regulatory strategy. From 2006 to 2015, he served in several senior roles at Seattle Genetics, most recently as Senior Vice President, Clinical Development. At Seattle Genetics, he helped write and supervise pivotal trials that ultimately led to the US registration of ADCETRIS for Hodgkin lymphoma and anaplastic large cell lymphoma in 2011, now approved in over 45 countries worldwide. From 2003 to 2006, Dr. Sievers served as Medical Director at Zymogenetics. He performed his training in pediatric hematology and oncology at the University of Washington and the Fred Hutchinson Cancer Research Center, and served on the faculty of both institutions for more than a decade. Dr. Sievers received both a B.A. in Biology and an M.D. from Brown University.


T-cell Lymphoma Forum - Faculty

www.tcellforum.com [cached]

Eric Sievers, MD
Trillium Therapeutics, Inc



transitions :: Longwoods.com

ftp.longwoods.com [cached]

Dr. Eric L. Sievers to Chief Medical Officer, Trillium Therapeutics Inc., Toronto, ON


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory